Abstract: Four 2,5-disubstituted pyrrole and two 2-disubstituted thiophene analogs of the natural products mycalazol 5 and mycalazal 2 have been prepared using the Stille coupling reaction. All four analogs displayed potent antiproliferating activity against several human cancer cell lines with IC 50 values in the nanomolar range.
INTRODUCTION
Natural products are an important source for the development of new anticancer drugs [1] . Seldom is a natural product useful directly as a drug, but more often natural products are important as lead compounds for the development of a new anticancer drug. In those cases, structural-activity relationship (SAR) studies become necessary. However, before SAR studies can be performed, the synthesis of new analogs of the natural product of interest must be conducted [2] . Analogs are synthesized in order to enhance the biological activity, but also for achieving selectivity toward, for example, cancer cells. The new analogs should ideally exhibit improved pharmacokinetic as well as pharmacodynamic properties [2] .
In 1997, Salvá and co-workers [3] reported the identification of 14 structurally related 2,5-disubstituted pyrroles from the northeastern Atlantic sponge Mycale micracanthoxea. The compounds exhibited interesting cytotoxic activity against several cancer cell lines. The presence of a saturated or an unsaturated carbon chain attached to the pyrrole ring characterizes these natural products. Recently, we reported the first total synthesis of mycalazol 5 (1) and mycalazal 2 (2) (Fig. 1) [4] . As part of our ongoing efforts on the synthesis and biological evaluation of polyunsaturated natural products [5] as potential new anticancer agents, we herein report the synthesis and antiproliferating activity of four new analogs of these naturally occurring 2,5-disubstituted pyrroles. The synthesis and biological evaluation of one 2-acyl thiophene analog and one 2-alkyl thiophene analog are also presented.
Recently, it was reported by Zhou, Nagle, and co-workers that 2,5-disubstituted pyrroles, such as 4 and 5, isolated from a Mycale sponge inhibited hypoxia-inducible factor-1 (HIF-1α) in a human breast cancer cell assay [6] . Identification of new inhibitors of HIF-1α is an attractive approach for the development of new anticancer agents [7] [8] [9] . However, limited information on the SAR of analogs of the mycalazol and mycalazal class of natural products has so far been published. Nabbs and Abell reported the synthesis and cytotoxic properties data of three saturated analogs of mycalazol 11 (3) [10] . Hence, *Paper based on a presentation made at the 18 th International Conference on Organic Synthesis (ICOS-18), Bergen, Norway, 1-6 August 2010. Other presentations are published in this issue, pp. 411-731.
‡ Corresponding author based on our published synthesis of mycalazol 5 (1), we decided to prepare analogs with an unsaturated C-20 side chain and a saturated C-20 side chain at the 2-position of the pyrrole ring. For comparison, we also decided to prepare the 2-acyl substituted thiophene 18 and the 2-alkyl substituted thiophene derivative 19 with a saturated C-20 side chain. These six compounds, as well as the natural products 1 and 2, were subjected to biological testing in four human cancer cell lines.
RESULTS AND DISCUSSION

Synthesis
The synthesis of analogs 13, 14, 15, and 16 started with the preparation of 5-(tri-n-butylstannyl)pyrrole-2-carboxaldehyde (10) from commercial available pyrrole 2-carboxaldehyde 8 [11] via the known compound 9a [12] (Scheme 1). First, an aqueous solution of dimethyl amine was reacted with pyrrole-2-carboxaldehyde (8) that yielded azafulvene 9a in a quantitative yield. Compound 9a was then treated with 2.3 equiv of n-butyl lithium followed by reaction with excess n-tributyltin chloride. This afforded the known azafulvene derivative 9b. Then aqueous hydrolysis of 9b afforded 5-(tri-n-butylstannyl)pyrrole-2-carboxaldehyde (10). (6), and eicosapentaenoic acid (7).
Scheme 1 Synthesis of stannyl pyrrole 10.
The commercially available eicosanoic acid (EA, 6) and eicosapentaenoic acid (EPA, 7) were converted into their respective acid chlorides 11 and 12 by reaction with oxalyl chloride in methylene chloride. The crude acid chlorides underwent Stille cross-coupling reaction [13] with the stannyl pyrrole 10 affording compounds 13 and 14 in 76 and 71 % yields, respectively (Scheme 2). Chemioselective reduction of the formyl group in 13 and 14 with Zn(BH 4 ) 2 [14] in THF at 0-25 °C afforded 15 and 16 in 88 and 93 % yields, respectively.
The 2-acyl thiophene analog 18 was prepared in 84 % yield from the commercially available 2-(tri-n-butylstannyl)pyrrole 17 and acid chloride 11 again using the Stille coupling. Reduction of the carbonyl group in 18 under standard hydrogenation conditions (Pd/C, H 2 , EtOH) in the presence of catalytic amounts of sulfuric acid afforded thiophene 19 in 87 % yield (Scheme 3). Spectral data were in agreement with the assigned structures. The preparation of mycalazol 5 (1) and mycalazal 2 (2) has previously been described [4] .
Biological results
Mycalazol 5 (1), mycalazal 2 (2) and the four pyrrole derivatives 13, 14, 15, and 16 and the two thiophene analogs 18 and 19 were applied to four human cancer cell lines for the determination of their in vitro antiproliferating activity [15] . The results are summarized in Table 1 . Mycalazol 5 (1) and mycalazal 2 (2) were the two most potent compounds in all four cell lines. In general, 1 was slightly more active than 2 exhibiting IC 50 values in the ranges 2.1-14.9 nM and 4.1-23.3 nM, respectively. This is in accord with the results reported by Salvá and co-workers [3] . Analogs 13 and 14 were less active than 1 and 2. Interestingly, the presence of both an acyl-group and a formyl-group in the 2-and 5-positions does not enhance the antiproliferating activity. The IC 50 values ranged from 11.3 to 22.9 nM for 14 and 13.0 to 31.1 nM for 13. Only a slight increase in activity was observed in all cell lines with a polyunsaturated C-20 side chain in compound 16 compared to the saturated derivative 15. Moreover, both compounds were less active than both mycalazol 5 (1) and mycalazal 2 (2). The IC 50 values ranged from 27.7 to 38.5 nM for 15 and 20.5 to 34.7 nM for 16. A further reduction was observed for the 2-acyl substituted thiophene 18 with IC 50 values from 45.5 to 58.7 nM. The 2-alkyl thiophene 19 was inactive in all cancer cell assays. The biological results reported herein indicated that the NH-pyrrole ring is important for the observed antiproliferating activity against all four human cancer cell lines. Moreover, both mycalazol 5 (1) and mycalazal 2 (2) as well as all new analogs except 19, exhibited potent activity in the noncancerous VERO cell line. These results, in combination with the results from the cancer cell lines, showed that the compounds exhibited low selectivity. Hence, other analogs of the mycalazols and mycalzals should be prepared with antiproliferating activity toward only the cancer cell lines.
CONCLUSION
The Stille cross-coupling reaction was employed for efficient syntheses of mycalazol and mycalazal analogs without protection of the NH-pyrrole. Moreover, the conservation of the all-Z-configuration of the methylene-interrupted double bonds was observed for natural products 1 and 2, as well as analogs 14 and 16. In vitro antiproliferating activity against four human cancer cell lines was determined. All four 2,5-disubstiuted pyrrole analogs revealed significant activity in both ovarian and melanoma human cancer cell lines. The most active analog was 14. For the thiophene analogs, only compound 18 exhibited antiproliferating activity. However, all analogs were less active than the natural products mycalazol 5 (1) and mycalazal 2 (2) and low selectivity was observed. Since inhibitors of HIF-1α continue to be of interest as potential remedies against various cancers, further structural-activity studies will focus on the synthesis and biological evaluation of additional analogs of mycalazol 5 (1). These efforts will be reported in due time. 
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